These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Selective inhibition of the A form of monoamine oxidase by 4-dimethylamino-alpha-methylphenylalkylamine derivatives in the rat. Ask AL; Hellström W; Norrman S; Ogren SO; Ross SB Neuropharmacology; 1982 Apr; 21(4):299-308. PubMed ID: 7088264 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of a ginkgo biloba extract (EGb 761) in functional tests for monoamine oxidase inhibition. Porsolt RD; Roux S; Drieu K Arzneimittelforschung; 2000 Mar; 50(3):232-5. PubMed ID: 10758773 [TBL] [Abstract][Full Text] [Related]
8. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro]. Gol'dina OA; Zagorevskiĭ VA; Lopatina KI; Sokolova TV; Gankina EM Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029 [TBL] [Abstract][Full Text] [Related]
9. Selective monoamine oxidase inhibitors. 3. Cyclic compounds related to 4-aminophenethylamine. Preparation and neuron-selective action of some 5-(2-aminoethyl)-2,3-dihydroindoles. Florvall L; Kumar Y; Ask AL; Fagervall I; Rényi L; Ross SB J Med Chem; 1986 Aug; 29(8):1406-12. PubMed ID: 3735309 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of MAO by substituted tryptamine analogues. Balsa D; Fernandez-Alvarez E; Tipton KF; Unzeta M J Neural Transm Suppl; 1990; 32():103-5. PubMed ID: 2089079 [TBL] [Abstract][Full Text] [Related]
11. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase. Fuller RW Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):32-7. PubMed ID: 4386711 [No Abstract] [Full Text] [Related]
12. [Activity of toloxatone, antidepressive agents and various other reserpine antagonists on three behavior tests, in the mouse treated with nialamide]. Gouret C; Raynaud G Therapie; 1975; 30(2):225-30. PubMed ID: 1080583 [No Abstract] [Full Text] [Related]
13. The kinetics of monoamine oxidase inhibition by three 2-indolylmethylamine derivatives. Cruces MA; Elorriaga C; Fernández-Alvarez E Biochem Pharmacol; 1990 Aug; 40(3):535-43. PubMed ID: 2383286 [TBL] [Abstract][Full Text] [Related]
14. [Selective inhibition of type A monoamine oxidase by pyrazidol]. Mashkovskiĭ MD; Gorkin VZ; Verevkina IV; Asnina VV; Tupikina SM Biull Eksp Biol Med; 1981 Feb; 91(2):169-71. PubMed ID: 7225552 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of rat brainstem monoamine oxidase activity by CGP 6085 A. Hurst JH; Kulakowski EC Life Sci; 1986 Oct; 39(16):1471-7. PubMed ID: 2430159 [TBL] [Abstract][Full Text] [Related]
16. Monoamine oxidase inhibitory effects of some 4-aminophenethylamine derivatives. Reyes-Parada M; Scorza MC; Silveira R; Dajas F; Costa G; Tipton KF; Cassels BK Biochem Pharmacol; 1994 Apr; 47(8):1365-71. PubMed ID: 7514408 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of monoamine oxidase by clorgyline and deprenyl in circumventricular structures of rat brain. Kinemuchi H; Wakui Y; Arai Y; Kamijo K Biochem Pharmacol; 1980 Oct; 29(20):2871-4. PubMed ID: 6776962 [No Abstract] [Full Text] [Related]
18. Enzyme-activated irreversible inhibitors of monoamine oxidase: phenylallylamine structure-activity relationships. McDonald IA; Lacoste JM; Bey P; Palfreyman MG; Zreika M J Med Chem; 1985 Feb; 28(2):186-93. PubMed ID: 3968682 [TBL] [Abstract][Full Text] [Related]
20. Selectivity of an indole-hydrazide derivative as inhibitor of mouse brain type A monoamine oxidase. Gurpegui M; Monge A; Fuentes JA Arzneimittelforschung; 1981; 31(10):1710-2. PubMed ID: 7198447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]